152 related articles for article (PubMed ID: 37711827)
1. Semiquantitative magnetic resonance imaging parameters for differentiating parotid pleomorphic adenoma from Warthin tumor.
He SN; Lu RC; Zhou JL; Wang B; Bi GL; Wu KH
Quant Imaging Med Surg; 2023 Sep; 13(9):6152-6163. PubMed ID: 37711827
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of MRI-based radiomic features for distinguishing Warthin tumor from pleomorphic adenoma: performance assessment using T2-weighted and post-contrast T1-weighted MR images.
Faggioni L; Gabelloni M; De Vietro F; Frey J; Mendola V; Cavallero D; Borgheresi R; Tumminello L; Shortrede J; Morganti R; Seccia V; Coppola F; Cioni D; Neri E
Eur J Radiol Open; 2022; 9():100429. PubMed ID: 35757232
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of maximum signal intensity on T1-weighted MRI images for differentiating parotid gland tumours along with pathological correlation.
Wei PY; Shao C; Huan T; Wang HB; Ding ZX; Han ZJ
Clin Radiol; 2021 Jun; 76(6):472.e19-472.e25. PubMed ID: 33731262
[TBL] [Abstract][Full Text] [Related]
4. Enhanced CT-based texture analysis and radiomics score for differentiation of pleomorphic adenoma, basal cell adenoma, and Warthin tumor of the parotid gland.
Chen F; Ge Y; Li S; Liu M; Wu J; Liu Y
Dentomaxillofac Radiol; 2023 Jan; 52(2):20220009. PubMed ID: 36367128
[TBL] [Abstract][Full Text] [Related]
5. Differentiating parotid tumors by quantitative signal intensity evaluation on MR imaging.
Matsusue E; Fujihara Y; Matsuda E; Tokuyasu Y; Nakamoto S; Nakamura K; Ogawa T
Clin Imaging; 2017; 46():37-43. PubMed ID: 28704680
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of parotid pleomorphic adenoma from Warthin tumor using signal intensity ratios on fat-suppressed T2-weighted magnetic resonance imaging.
Lin W; Ye W; Ma J; Wang S; Chen P; Yang Y; Yin B
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Mar; 137(3):310-319. PubMed ID: 38195353
[TBL] [Abstract][Full Text] [Related]
7. Value of T2-weighted-based radiomics model in distinguishing Warthin tumor from pleomorphic adenoma of the parotid.
Hu Z; Guo J; Feng J; Huang Y; Xu H; Zhou Q
Eur Radiol; 2023 Jun; 33(6):4453-4463. PubMed ID: 36502461
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of Benign From Malignant Parotid Gland Tumors Using Conventional MRI Based on Radiomics Nomogram.
Qi J; Gao A; Ma X; Song Y; Zhao G; Bai J; Gao E; Zhao K; Wen B; Zhang Y; Cheng J
Front Oncol; 2022; 12():937050. PubMed ID: 35898886
[TBL] [Abstract][Full Text] [Related]
9. Effects of region of interest sizes on apparent diffusion coefficient measurements of pleomorphic adenoma, Warthin tumor, and normal parotid parenchyma.
Sun Q; Ma C; Dong M; Jiang M; Tao X
Quant Imaging Med Surg; 2019 Apr; 9(4):681-690. PubMed ID: 31143659
[TBL] [Abstract][Full Text] [Related]
10. Imaging quality of PROPELLER diffusion-weighted MR imaging and its diagnostic performance in distinguishing pleomorphic adenomas from Warthin tumors of the parotid gland.
Liu YJ; Lee YH; Chang HC; Chung HW; Wang CW; Juan CH; Chu YH; Lee JC; Juan CJ
NMR Biomed; 2020 May; 33(5):e4282. PubMed ID: 32124504
[TBL] [Abstract][Full Text] [Related]
11. An ultrasound-based ensemble machine learning model for the preoperative classification of pleomorphic adenoma and Warthin tumor in the parotid gland.
He Y; Zheng B; Peng W; Chen Y; Yu L; Huang W; Qin G
Eur Radiol; 2024 Apr; ():. PubMed ID: 38570381
[TBL] [Abstract][Full Text] [Related]
12. Deep learning based ultrasound analysis facilitates precise distinction between parotid pleomorphic adenoma and Warthin tumor.
Liu XH; Miao YY; Qian L; Shi ZT; Wang Y; Su JL; Chang C; Chen JY; Chen JG; Li JW
Front Oncol; 2024; 14():1337631. PubMed ID: 38476360
[TBL] [Abstract][Full Text] [Related]
13. Added value of susceptibility-weighted imaging to diffusion-weighted imaging in the characterization of parotid gland tumors.
Jiang JS; Zhu LN; Chen W; Chen L; Su GY; Xu XQ; Wu FY
Eur Arch Otorhinolaryngol; 2020 Oct; 277(10):2839-2846. PubMed ID: 32328768
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of various salivary gland tumours using diffusion-weighted MRI and dynamic contrast-enhanced MRI.
Kushwaha M; Kumar J; Garg A; Singh I; Khurana N
Pol J Radiol; 2023; 88():e203-e215. PubMed ID: 37234459
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted imaging with histogram analysis of the apparent diffusion coefficient maps in the diagnosis of parotid tumours.
Abdel Razek AAK; Gadelhak BN; El Zahabey IA; Elrazzak GAEA; Mowafey B
Int J Oral Maxillofac Surg; 2022 Feb; 51(2):166-174. PubMed ID: 33895039
[TBL] [Abstract][Full Text] [Related]
16. Texture analysis in the characterization of parotid salivary gland lesions: A study on MR diffusion weighted imaging.
Nardi C; Tomei M; Pietragalla M; Calistri L; Landini N; Bonomo P; Mannelli G; Mungai F; Bonasera L; Colagrande S
Eur J Radiol; 2021 Mar; 136():109529. PubMed ID: 33453571
[TBL] [Abstract][Full Text] [Related]
17. A multiparametric analysis based on DCE-MRI to improve the accuracy of parotid tumor discrimination.
Xu Z; Zheng S; Pan A; Cheng X; Gao M
Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2228-2234. PubMed ID: 31372671
[TBL] [Abstract][Full Text] [Related]
18. Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings.
Yamamoto T; Kimura H; Hayashi K; Imamura Y; Mori M
Neuroradiology; 2018 Aug; 60(8):803-812. PubMed ID: 29968073
[TBL] [Abstract][Full Text] [Related]
19. Improving the diagnosis of common parotid tumors via the combination of CT image biomarkers and clinical parameters.
Zhang D; Li X; Lv L; Yu J; Yang C; Xiong H; Liao R; Zhou B; Huang X; Liu X; Tang Z
BMC Med Imaging; 2020 Apr; 20(1):38. PubMed ID: 32293304
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of salivary gland tumors through tumor heterogeneity: a comparison between pleomorphic adenoma and Warthin tumor using CT texture analysis.
Jung YJ; Han M; Ha EJ; Choi JW
Neuroradiology; 2020 Nov; 62(11):1451-1458. PubMed ID: 32621023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
